Articles
 News Headlines
 Journal Headlines

  Home
  Archives
  Site Map
   
April 16, 2014
 
About AIDScience
Contact Us
——
NeuroAIDS
 
 
 
 

Search Journal Headlines Archive
 
Enter a word or phrase you want to search for:


Found: 405 records.
Note: For details on a journal headline, click on the title
Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection
Vaccine. (Posted: December 11, 2003)

The functional consequences of delivery of HIV-1 Nef to dendritic cells using an adenoviral vector
Vaccine. (Posted: December 11, 2003)

Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines
Virology. (Posted: December 11, 2003)

HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses
Proc. Natl. Acad. Sci. USA. (Posted: December 8, 2003)

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development
Proc. Natl. Acad. Sci. USA. (Posted: December 8, 2003)

Review: Immunodeficiency virus exploitation of dendritic cells in the early steps of infection
Journal of Leukocyte Biology. (Posted: December 2, 2003)

Review: The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys
Journal of Leukocyte Biology. (Posted: December 2, 2003)

Review: Macrophage HIV-1 infection and the gastrointestinal tract reservoir
Journal of Leukocyte Biology. (Posted: December 2, 2003)

HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China
AIDS. (Posted: November 20, 2003)

Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1
Journal of Immunology. (Posted: November 12, 2003)

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals
Vaccine. (Posted: November 12, 2003)

The first generation of candidate HIV-1 vaccines can induce antibodies able to neutralize primary isolates in assays with extended incubation phases
Vaccine. (Posted: November 12, 2003)

The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients
Vaccine. (Posted: November 12, 2003)

Modified Vaccinia Virus Ankara (MVA) priming and Fowlpox Virus booster elicit stronger CD8+ T cell response in mice against an HIV-1 epitope than DNA-Poxvirus prime-booster approach
Biotechnology and Applied Biochemistry. (Posted: November 12, 2003)

Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity
Journal of Immunology. (Posted: November 11, 2003)

Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses
Journal of Immunology. (Posted: November 11, 2003)

M cell DNA vaccination for CTL immunity to HIV
Journal of Immunology. (Posted: November 11, 2003)

Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge
Journal of Immunology. (Posted: November 11, 2003)

Microparticles and nanoparticles as delivery systems for DNA vaccines
Crit. Rev. Ther. Drug. Carrier Syst.. (Posted: November 10, 2003)

Attenuated nef DNA vaccine construct induces cellular immune response: role in HIV-1 multiprotein vaccine
Immunology Letters. (Posted: November 10, 2003)

Safety evaluation of GX-12, a new HIV therapeutic vaccine: Investigation of integration into the host genome and expression in the reproductive organs
Intervirology. (Posted: November 10, 2003)

Peptide immunogens based on the envelope region of HIV-1 are recognized by HIV/AIDS patient polyclonal antibodies and induce strong humoral immune responses in mice and rabbits
Molecular Immunology. (Posted: November 10, 2003)

Gradual adaptation of HIV to human host populations: good or bad news?
Nature Medicine. (Posted: November 10, 2003)

IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaques
AIDS Research and Human Retroviruses. (Posted: November 7, 2003)

Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: Associations with viral replication and progression
Journal of Medical Virology. (Posted: November 7, 2003)

Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O
Virus Research. (Posted: November 7, 2003)

Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets
Blood. (Posted: November 7, 2003)

Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: Poorer control of a pathogenic viral challenge
AIDS Research and Human Retroviruses. (Posted: November 7, 2003)

Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways
Journal of Biological Chemistry. (Posted: November 6, 2003)

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS
Journal of Virology. (Posted: November 3, 2003)

Evidence for Gag p24-specific CD4 T cells with reduced susceptibility to R5 HIV-1 infection in a UK cohort of HIV-exposed-seronegative subjects
AIDS. (Posted: October 29, 2003)

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic HIV-1 isolate
Journal of Virology. (Posted: October 27, 2003)

Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge
Journal of Virology. (Posted: October 27, 2003)

Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes
Journal of Virology. (Posted: October 27, 2003)

Microarray profiling of antibody responses against simian-human immunodeficiency virus: Postchallenge convergence of reactivities independent of host histocompatibility type and vaccine regimen
Journal of Virology. (Posted: October 23, 2003)

Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: Characterization of CD8+-T-cell epitopes recognized
Journal of Virology. (Posted: October 23, 2003)

Oral vaccination of mice with adenoviral vectors Is not impaired by preexisting immunity to the vaccine carrier
Journal of Virology. (Posted: October 22, 2003)

Enhancement of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope gene fused to the gene coding for soluble CTLA4
Journal of Virology. (Posted: October 22, 2003)

Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env expressed from a single rhabdovirus-based vaccine vector genome
Journal of Virology. (Posted: October 22, 2003)

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine
Journal of Virology. (Posted: October 22, 2003)

Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans
Journal of Infectious Diseases. (Posted: October 14, 2003)

Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans
AIDS. (Posted: October 9, 2003)

AIDS vaccines that allow HIV-1 to infect and escape immunologic control: A mathematic analysis of mass vaccination
Journal of Acquired Immune Deficiency Syndromes. (Posted: October 9, 2003)

Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies
Journal of Immunology. (Posted: October 6, 2003)

Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells
Journal of Immunology. (Posted: October 6, 2003)

Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL
Journal of Immunology. (Posted: October 6, 2003)

Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection
Journal of Immunology. (Posted: October 6, 2003)

How the SARS vaccine effort can learn from HIV—speeding towards the future, learning from the past
Vaccine. (Posted: October 2, 2003)

Ii-Key/MHC class II epitope hybrid peptide vaccines for HIV
Vaccine. (Posted: October 2, 2003)

Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
Vaccine. (Posted: October 2, 2003)

Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa
Vaccine. (Posted: October 2, 2003)

Analysis of the immunogenic properties of a single-chain polypeptide analogue of the HIV-1 gp120-CD4 complex in transgenic mice that produce human immunoglobulins
Vaccine. (Posted: October 2, 2003)

Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach
Vaccine. (Posted: October 2, 2003)

HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the MHC class II compartment, and elicits enhanced immune responses
Journal of Biological Chemistry. (Posted: September 30, 2003)

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA)
Peptides. (Posted: September 30, 2003)

Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4(+) and CD8(+) T-Cell responses
Journal of Acquired Immune Deficiency Syndromes. (Posted: September 29, 2003)

Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses
Journal of Acquired Immune Deficiency Syndromes. (Posted: September 29, 2003)

SIVagm: Genetic and biological features associated with replication
Frontiers in Bioscience. (Posted: September 29, 2003)

CD4(+) T cell signaling in the natural SIV host — Implications for disease pathogenesis
Frontiers in Bioscience. (Posted: September 29, 2003)

Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials
Biometrics. (Posted: September 29, 2003)

Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys
Frontiers in Bioscience. (Posted: September 29, 2003)

Enhanced cell-mediated IFN-gamma-secreting activity against the HIV-1(IIIB)V3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering
Biochem. Biophys. Res. Commun.. (Posted: September 29, 2003)

Health and human rights: Thorny issues in the ethics of AIDS vaccine trials
The Lancet. (Posted: September 23, 2003)

Health and human rights: HIV-1 care in resource-poor settings: a view from Haiti
The Lancet. (Posted: September 23, 2003)

Health and human rights: Provision of treatment in HIV-1 vaccine trials in developing countries
The Lancet. (Posted: September 23, 2003)

Health and human rights: Not if but how? Caring for HIV-1 vaccine trial participants in South Africa
The Lancet. (Posted: September 23, 2003)

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1
Journal of Virology. (Posted: September 16, 2003)

Yeast-derived human immunodeficiency virus type 1 p55gag virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8+ T cells by cross-presentation of DCs
Journal of Virology. (Posted: September 15, 2003)

Cellular immunity elicited by HIV-1/SIV DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies
Journal of Virology. (Posted: September 15, 2003)

Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells
Journal of Virology. (Posted: September 15, 2003)

ELDKWA-epitope-specific monoclonal antibodies inhibit HIV envmediated syncytium formation
Immunobiology. (Posted: September 12, 2003)

Synthetic vaccines: The role of adjuvants in immune targeting
Current Medicinal Chemistry. (Posted: September 2, 2003)

Unique risks to volunteers in HIV vaccine trials
Journal of Investigative Medicine. (Posted: September 2, 2003)

T cell targeted immune enhancement yields effective T cell adjuvants
International Immunopharmacology. (Posted: September 2, 2003)

Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B
Journal of Virology. (Posted: August 29, 2003)

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system
Journal of Virology. (Posted: August 29, 2003)

Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities
Journal of Virology. (Posted: August 29, 2003)

Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys
Journal of Virology. (Posted: August 29, 2003)

Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen
Journal of Immunology. (Posted: August 20, 2003)

Most highly exposed seronegative men lack HIV-1-specific, IFN-{gamma}-secreting T cells
Journal of Immunology. (Posted: August 20, 2003)

Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda
AIDS. (Posted: August 20, 2003)

Prime-boost vaccination with HIV-1 gag protein and cytosine phosphate guanosine oligodeoxynucleotide, followed by adenovirus, induces sustained and robust humoral and cellular immune responses
Journal of Immunology. (Posted: August 20, 2003)

Convergent evolution of SIV env after independent inoculation of rhesus macaques with infectious proviral DNA
Vaccine. (Posted: August 19, 2003)

AIDSVAX results: an important open question
Vaccine. (Posted: August 19, 2003)

Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA
Vaccine. (Posted: August 19, 2003)

Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr–SIVenv/rev and Ad5hr–SIVgag recombinants
Vaccine. (Posted: August 19, 2003)

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha
Journal of Experimental Medicine. (Posted: August 18, 2003)

A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand
AIDS Research and Human Retroviruses. (Posted: August 18, 2003)

Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
Journal of Molecular Biology. (Posted: August 18, 2003)

Heterogeneity of the simian immunodeficiency virus (SIV) specific CD8(+) T-cell response in mucosal tissues during SIV primary infection
Microbes and Infection. (Posted: August 18, 2003)

Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes
Journal of General Virology. (Posted: August 14, 2003)

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
Journal of Virology. (Posted: August 14, 2003)

Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-SIV env/rev, gag, and/or nef vaccines and boosted with SIV gp120
Journal of Virology. (Posted: August 8, 2003)

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines
Journal of Virology. (Posted: August 8, 2003)

Induction of protective immune responses against R5 HIV-1 infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells
Journal of Virology. (Posted: August 8, 2003)

Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells
AIDS. (Posted: August 4, 2003)

Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env
Blood. (Posted: July 29, 2003)

In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice
Archives of Pharmacal Research. (Posted: July 29, 2003)

Role of complement in the control of HIV dynamics and pathogenesis
Vaccine. (Posted: July 29, 2003)

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1
FEMS Immunology and Medical Microbiology. (Posted: July 29, 2003)

Specific nature of cellular immune responses elicited by chimpanzees against HIV-1
Human Immunology. (Posted: July 29, 2003)

Innate and adaptive mucosal immunity in protection against HIV infection
Vaccine. (Posted: July 29, 2003)

Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 gag in mice
AIDS Research and Human Retroviruses. (Posted: July 29, 2003)

Identification and characterization of HLA-A*3303-restricted, HIV type 1 pol- and gag-derived cytotoxic T cell epitopes
AIDS Research and Human Retroviruses. (Posted: July 29, 2003)

First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection
Virology. (Posted: July 25, 2003)

Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251
Virology. (Posted: July 25, 2003)

DNA vaccination of macaques by a full-genome simian/human immunodeficiency virus type 1 plasmid chimera that produces non-infectious virus particles
Journal of General Virology. (Posted: July 23, 2003)

Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities
Journal of Acquired Immune Deficiency Syndromes. (Posted: July 23, 2003)

Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients
Journal of Virology. (Posted: July 16, 2003)

A DNA vaccine containing inverted terminal repeats from adeno-associated virus increases immunity to HIV
Journal of Gene Medicine. (Posted: July 16, 2003)

Improved protection of rhesus macaques against intrarectal SIVmac251 challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen
Journal of Virology. (Posted: July 16, 2003)

Anti-human immunodeficiency virus-gag CD8(+) memory T cells generated in vitro from Listeria-immunized mice
Immunology. (Posted: July 16, 2003)

Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant
European Journal of Immunology. (Posted: July 16, 2003)

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines
AIDS Reviews. (Posted: July 15, 2003)

Antibody protection: passive immunization of neonates against oral AIDS virus challenge
Vaccine. (Posted: July 11, 2003)

Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals
Vaccine. (Posted: July 11, 2003)

Immunogenicity of DNA vaccines that direct the coincident expression of the 120 kDa glycoprotein of human immunodeficiency virus and the catalytic domain of cholera toxin
Vaccine. (Posted: July 11, 2003)

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1
FEMS Immunology and Medical Microbiology. (Posted: July 11, 2003)

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials
Vaccine. (Posted: July 11, 2003)

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults
Journal of Infectious Diseases. (Posted: July 10, 2003)

Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice
Proc. Natl. Acad. Sci. USA. (Posted: July 10, 2003)

HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals
Journal of Immunology. (Posted: July 10, 2003)

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials
Journal of Infectious Diseases. (Posted: July 10, 2003)

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression
AIDS Research and Human Retroviruses. (Posted: July 2, 2003)

Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O
AIDS Research and Human Retroviruses. (Posted: July 2, 2003)

Kunjin virus replicon vectors for human immunodeficiency virus vaccine development
Journal of Virology. (Posted: June 30, 2003)

Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1
Journal of Virology. (Posted: June 30, 2003)

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
Science. (Posted: June 27, 2003)

The need for a global HIV vaccine enterprise
Science. (Posted: June 27, 2003)

Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection
Journal of Immunology. (Posted: June 27, 2003)

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
Nature Medicine. (Posted: June 24, 2003)

Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences
Journal of Virology. (Posted: June 17, 2003)

Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys
Journal of Virology. (Posted: June 16, 2003)

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene
Journal of Virology. (Posted: June 16, 2003)

The association between hepatitis C virus and HIV-1 in preparatory cohorts for HIV vaccine trials in Thailand
AIDS. (Posted: June 12, 2003)

Viewpoint — Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
Lancet. (Posted: May 27, 2003)

A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12
Journal of Virology. (Posted: May 27, 2003)

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against HIV Env systemically and in the genitorectal draining lymph nodes
Journal of Virology. (Posted: May 27, 2003)

HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children
Journal of Immunology. (Posted: May 27, 2003)

Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins
Virology. (Posted: May 21, 2003)

Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines
Journal of Virology. (Posted: May 20, 2003)

Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a HIV-1 gag gene
Journal of Virology. (Posted: May 20, 2003)

Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women
AIDS. (Posted: May 19, 2003)

Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization
AIDS. (Posted: May 19, 2003)

Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis
Journal of Clinical Investigation. (Posted: May 16, 2003)

Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants
Vaccine. (Posted: May 13, 2003)

Estimation of "needs" and "probable uptake" for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)
Vaccine. (Posted: May 13, 2003)

Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination
Vaccine. (Posted: May 13, 2003)

Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming
Vaccine. (Posted: May 13, 2003)

The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag
Journal of Immunology. (Posted: May 12, 2003)

Identification of immunodominant epitopes in inactivated Tat-vaccinated healthy and HIV-1-infected volunteers
Journal of Acquired Immune Deficiency Syndromes. (Posted: May 12, 2003)

Infection of macaques with an R5-tropic SHIV bearing a chimeric envelope carrying subtype E V3 loop among subtype B framework
Archives of Virology. (Posted: May 12, 2003)

HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand
Journal of Acquired Immune Deficiency Syndromes. (Posted: May 12, 2003)

Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones
Journal of Clinical Virology. (Posted: May 12, 2003)

HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals
Clinical and Experimental Immunology. (Posted: May 9, 2003)

Induction of broad and potent anti-HIV immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles
Journal of Virology. (Posted: May 2, 2003)

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120
Journal of Virology. (Posted: May 2, 2003)

Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants To enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins
Journal of Virology. (Posted: May 1, 2003)

Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
Journal of Virology. (Posted: May 1, 2003)

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses
Journal of Immunological Methods. (Posted: April 26, 2003)

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection
Biomedicine & Pharmacotherapy. (Posted: April 26, 2003)

Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1
Journal of Virology. (Posted: April 17, 2003)

Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Proc. Natl. Acad. Sci. USA. (Posted: April 14, 2003)

Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV89.6
Virology. (Posted: April 14, 2003)

Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner
Journal of Infectious Diseases. (Posted: April 7, 2003)

HIV-1 vaccine development: Constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb
Biochemistry. (Posted: April 4, 2003)

Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination
Journal of Virology. (Posted: April 2, 2003)

Viremia control despite escape from a rapid and potent autologous neutralizing antibody response after therapy cessation in an HIV-1-infected individual
Journal of Immunology. (Posted: March 25, 2003)

Evaluation in rabbits of different anti-SHIV vaccine strategies based on DNA/fowlpox priming and virus-like particle boosting
FEMS Immunology and Medical Microbiology. (Posted: March 20, 2003)

Human immunodeficiency virus seropositivity among uninfected HIV vaccine recipients
Journal of Infectious Diseases. (Posted: March 17, 2003)

Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein
Journal of Virology. (Posted: March 17, 2003)

Immunogenicity of a recombinant HIV canarypox vaccine in HIV-seronegative Ugandan volunteers: Results of the HIV Network for Prevention Trials 007 vaccine study
Journal of Infectious Diseases. (Posted: March 17, 2003)

Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12
Journal of Virology. (Posted: March 17, 2003)

nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes
Journal of Virology. (Posted: March 17, 2003)

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity
Proc. Natl. Acad. Sci. USA. (Posted: March 17, 2003)

Primary African HIV clade A and D isolates: Effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B
AIDS Research and Human Retroviruses. (Posted: March 10, 2003)

A new perspective on V3 phenotype prediction
AIDS Research and Human Retroviruses. (Posted: March 10, 2003)

Characterization and selection of HIV-1 subtype C isolates for use in vaccine development
AIDS Research and Human Retroviruses. (Posted: March 10, 2003)

Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus
Journal of Virology. (Posted: March 6, 2003)

Candidate HIV/AIDS vaccines: Lessons learned from the world's first phase III efficacy trials
AIDS. (Posted: March 4, 2003)

Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand
Journal of Immunology. (Posted: February 27, 2003)

Prime boost vaccination strategies: CD8 T cell numbers, protection, and Th1 bias
Journal of Immunology. (Posted: February 27, 2003)

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Nature. (Posted: February 27, 2003)

Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men
AIDS. (Posted: February 25, 2003)

Estimating cumulative probabilities from incomplete longitudinal binary responses with application to HIV vaccine trials
Statistics in Medicine. (Posted: February 21, 2003)

Quantitative assessment of antigen-specific CD8+T cells in the mouse: application to vaccine research
Immunology Letters. (Posted: February 21, 2003)

Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor
Journal of Virology. (Posted: February 19, 2003)

SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization
Journal of Virology. (Posted: February 19, 2003)

Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system
Journal of Virology. (Posted: February 19, 2003)

Tat-neutralizing antibodies in vaccinated macaques
Journal of Virology. (Posted: February 19, 2003)

Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials
Journal of Acquired Immune Deficiency Syndromes. (Posted: February 19, 2003)

Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies
Journal of Biological Chemistry. (Posted: February 12, 2003)

Comparison between Env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults
Journal of Acquired Immune Deficiency Syndromes. (Posted: February 12, 2003)

Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or Interferon-g
Virology. (Posted: February 12, 2003)

Construction and immunogenicity in a prime–boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine
Journal of General Virology. (Posted: February 10, 2003)

Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat
Vaccine. (Posted: February 10, 2003)

HIV type 1 subtypes among bar and hotel workers in Moshi, Tanzania
AIDS Research and Human Retroviruses. (Posted: February 10, 2003)

Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice
Journal of Medical Virology. (Posted: February 5, 2003)

A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus macaques
Vaccine. (Posted: February 4, 2003)

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella
Vaccine. (Posted: February 4, 2003)

Oral recombinant Mycobacterium bovis bacillus Calmette-Guerin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity
Vaccine. (Posted: February 4, 2003)

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic
Blood. (Posted: February 4, 2003)

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost
Journal of General Virology. (Posted: February 4, 2003)

Reviews on human immunodeficiency virus central nervous system disease
Journal of Neurovirology. (Posted: February 4, 2003)

A systematic comparison of methods to measure HIV-1 specific CD8 T cells
Journal of Immunological Methods. (Posted: February 4, 2003)

Antigen burden is a major determinant of human immunodeficiency virus specific CD8+ T cell maturation state: Potential implications for therapeutic immunization
Journal of Infectious Diseases. (Posted: February 4, 2003)

Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies
Virology. (Posted: February 4, 2003)

Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
Nature Biotechnology. (Posted: February 4, 2003)

Virus-like particle and DNA-based candidate AIDS vaccines
Vaccine. (Posted: February 4, 2003)

Priming of human immunodeficiency virus type 1 (HIV-1) specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins
Journal of Infectious Diseases. (Posted: February 3, 2003)

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: Defining T cell responses as potential correlates of immunity
Journal of Infectious Diseases. (Posted: February 3, 2003)

Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance responses to immunization: Results of A5046s
Journal of Infectious Diseases. (Posted: February 3, 2003)

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region
Journal of Virology. (Posted: January 31, 2003)

Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system
Journal of Virology. (Posted: January 31, 2003)

Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation
AIDS. (Posted: January 30, 2003)

CD4-dependent and CD4-independent HIV-2: consequences for neutralization
AIDS. (Posted: January 30, 2003)

Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques
AIDS. (Posted: January 30, 2003)

A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag
Journal of Immunology. (Posted: January 23, 2003)

Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus
Journal of Virology. (Posted: January 22, 2003)

Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites
Journal of Virology. (Posted: January 22, 2003)

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d
Journal of Virology. (Posted: January 22, 2003)

Scaling HIV vaccine attitudes among gay men in Sydney, Australia
AIDS Research and Human Retroviruses. (Posted: January 16, 2003)

Phase I trial of a therapeutic HIV type 1 vaccine, Vacc-4x, in HIV type 1-infected individuals with or without antiretroviral therapy
AIDS Research and Human Retroviruses. (Posted: January 16, 2003)

Effect of promoters on cellular immune response induced by recombinant fowlpox virus expressing multi-epitope polypeptides from HIV-1
Biotechnology and Applied Biochemistry. (Posted: January 13, 2003)

Is HIV superinfection worrisome?
Lancet. (Posted: January 13, 2003)

Synthetic AIDS vaccine by targeting HIV receptor
Vaccine. (Posted: January 13, 2003)

Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya
Vaccine. (Posted: January 13, 2003)

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating Virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses
Journal of Immunology. (Posted: January 12, 2003)

Travel and the spread of HIV-1 genetic variants
Lancet Infectious Diseases. (Posted: January 9, 2003)

Course and outcome of pregnancy in 54 persistently HIV-1-seronegative sex workers and their infants
Journal of Reproductive Medicine. (Posted: January 8, 2003)

Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells
Journal of Virology. (Posted: January 6, 2003)

Prevention of disease induced by a partially heterologous AIDS virus in Rhesus monkeys by using an adjuvanted multicomponent protein vaccine
Journal of Virology. (Posted: January 6, 2003)

Control of viremia and prevention of SHIV-induced disease in Rhesus macaques immunized with recombinant vaccinia viruses plus inactivated SIV and HIV-1 particles
Journal of Virology. (Posted: January 6, 2003)

Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection
Journal of Virology. (Posted: January 6, 2003)

Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIVSF162P3 maps to envelope gp120
Journal of Virology. (Posted: January 6, 2003)

Immunization of newborn Rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251
Journal of Virology. (Posted: January 3, 2003)

Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8+ cytotoxic T lymphocytes
Journal of Virology. (Posted: January 3, 2003)

Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus
Journal of Virology. (Posted: January 3, 2003)

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
Journal of Virology. (Posted: January 2, 2003)

Concordant modulation of neutralization resistance and high infectivity of the primary HIV-1 MN strain and definition of a potential gp41 binding site in gp120
Journal of Virology. (Posted: January 2, 2003)

Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
Journal of Virology. (Posted: January 2, 2003)

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial
Journal of Acquired Immune Deficiency Syndromes. (Posted: December 26, 2002)

Therapeutic dendritic-cell vaccine for simian AIDS
Nature Medicine. (Posted: December 24, 2002)

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
Nature. (Posted: December 17, 2002)

Recombinant multi-epitope vaccine induced predefined epitope-specific antibodies against HIV-1
Immunology Letters. (Posted: December 17, 2002)

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells
Journal of Immunology. (Posted: December 8, 2002)

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev
AIDS. (Posted: December 4, 2002)

Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions
AIDS. (Posted: December 4, 2002)

HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades
AIDS. (Posted: December 3, 2002)

Immune responses against SIV envelope glycoprotein, using recombinant SV40 as a vaccine delivery vector
Vaccine. (Posted: November 25, 2002)

Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre- and postchallenge CD4(+) and CD8(+) T cell responses
Journal of Immunology. (Posted: November 18, 2002)

Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion
Journal of Virology. (Posted: November 12, 2002)

Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development
Virology. (Posted: November 12, 2002)

The functional CD8 T cell response to HIV becomes type-specific in progressive disease
Journal of Clinical Investigation. (Posted: November 6, 2002)

HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades
AIDS. (Posted: October 31, 2002)

Development of HIV-1 Nef vaccine components: immunogenicity study of Nef mutants lacking myristoylation and dileucine motif in mice
Vaccine. (Posted: October 31, 2002)

Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
Journal of Virology. (Posted: October 31, 2002)

Both mMucosal and systemic routes of immunization with the live, attenuated NYVAC/SIVgpe recombinant vaccine result in Gag-specific CD8+ T-cell responses in mucosal tissues of macaques
Journal of Virology. (Posted: October 31, 2002)

Evaluation in rhesus macaques of Tat and Rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08
DNA and Cell Biology. (Posted: October 25, 2002)

A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L
Proc. Natl. Acad. Sci. USA. (Posted: October 25, 2002)

Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus
Virology. (Posted: October 25, 2002)

Lymphoid activation: a confounding factor in AIDS vaccine development?
Journal of General Virology. (Posted: October 25, 2002)

In vivo priming of HIV-specific CTLs determines selective cross-reactive immune responses against poorly immunogenic HIV-natural variants
Journal of Immunology. (Posted: October 25, 2002)

HIV-1 Tat-based vaccines: From basic science to clinical trials
DNA and Cell Biology. (Posted: October 25, 2002)

Targeting Tat and IFN alpha as a therapeutic AIDS vaccine
DNA and Cell Biology. (Posted: October 25, 2002)

Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes
DNA and Cell Biology. (Posted: October 25, 2002)

Prime-boost immunization with DNA and MVA vectors expressing herpes simplex virus-2 glycoprotein d elicits greater specific antibody and cytokine responses than DNA vaccine alone.
The Journal of Infectious Diseases. (Posted: October 21, 2002)

Preparation of clinical-grade recombinant canarypox human immunodeficiency virus vaccine loaded human dendritic cells
The Journal of Infectious Diseases. (Posted: October 21, 2002)

Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection
Journal of Virology. (Posted: October 18, 2002)

A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine
Vaccine. (Posted: October 11, 2002)

Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques
Journal of Medical Primatology. (Posted: October 11, 2002)

Characterization of CD4+T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus
Journal of Medical Primatology. (Posted: October 11, 2002)

Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates
Journal of Medical Primatology. (Posted: October 11, 2002)

Cross-clade T lymphocyte-mediated immunity to HIV type 1: Implications for vaccine design and immunodetection assays
AIDS Research and Human Retroviruses. (Posted: October 11, 2002)

AIDS vaccines, immunology, and what we have learned
The AIDS Reader. (Posted: October 10, 2002)

Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments
Journal of Human Virology. (Posted: October 7, 2002)

Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41
AIDS. (Posted: October 1, 2002)

Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4(+) T cells
Clinical and Experimental Immunology. (Posted: September 23, 2002)

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV
Vaccine. (Posted: September 14, 2002)

Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element
DNA and Cell Biology. (Posted: September 14, 2002)

Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines
Journal of Virology. (Posted: September 14, 2002)

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine
Vaccine. (Posted: September 14, 2002)

Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with HIV gag DNA vaccines
Journal of Virology. (Posted: September 4, 2002)

Next generation DNA vaccines for HIV-1
Journal of Liposome Research. (Posted: September 3, 2002)

Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand
Journal of Acquired Immune Deficiency Syndromes. (Posted: September 3, 2002)

DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses
Blood. (Posted: September 3, 2002)

Design and tests of an HIV vaccine
British Medical Bulletin. (Posted: August 29, 2002)

HIV-1 therapeutic vaccines
Journal of Infection. (Posted: August 19, 2002)

Semi-allogeneic vaccines for patients with cancer and AIDS
Journal of Immunotherapy. (Posted: August 19, 2002)

Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects
Journal of Acquired Immune Deficiency Syndromes. (Posted: August 19, 2002)

The HIV-1 vaccine race
Cell. (Posted: August 19, 2002)

A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice
Proc. Natl. Acad. Sci. USA. (Posted: August 15, 2002)

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy
Lancet Infectious Diseases. (Posted: August 2, 2002)

Strategies for an HIV vaccine
Journal of Clinical Investigation. (Posted: July 29, 2002)

The development of HIV-1 subtype C vaccines for southern Africa
IUBMB Life. (Posted: July 29, 2002)

Alphavirus replicon particles as candidate HIV vaccines
IUBMB Life. (Posted: July 29, 2002)

Immuno-informatics: Mining genomes for vaccine components
Immunology and Cell Biology. (Posted: July 24, 2002)

T-lymphocyte epitope identification and their use in vaccine development for HIV-1
Frontiers in Bioscience. (Posted: July 24, 2002)

Human Immunodeficiency Virus-Specific CD8+ T Cells in Human Breast Milk
Journal of Virology. (Posted: July 19, 2002)

AIDS Vaccination Studies Using an Ex Vivo FIV Model: Failure To Protect and Possible Enhancement of Challenge Infection by Four Cell-Based Vaccines Prepared with Autologous Lymphoblasts
Journal of Virology. (Posted: July 19, 2002)

Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines
Journal of Virology. (Posted: July 19, 2002)

Enhanced Presentation of MHC Class I-Restricted HIV-1 Gag-Specific Epitopes after DNA Immunization with Vectors Coding for Vesicular Stomatitis Virus Glycoprotein- Pseudotyped HIV-1 Gag Particles
Journal of Virology. (Posted: July 19, 2002)

Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C
Vaccine. (Posted: July 19, 2002)

Private demand for a HIV/AIDS vaccine: evidence from Guadalajara, Mexico
Vaccine. (Posted: July 19, 2002)

Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection
Archives of Virology. (Posted: July 5, 2002)

HIV/AIDS treatment and HIV vaccines for Africa
Lancet. (Posted: June 28, 2002)

Diversity considerations in HIV-1 vaccine selection
Science. (Posted: June 28, 2002)

HIV-1 diversity and vaccine development
Science. (Posted: June 28, 2002)

Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines
AIDS Research and Human Retroviruses. (Posted: June 28, 2002)

Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in Rhesus macaques
Vaccine. (Posted: June 25, 2002)

Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge
Vaccine. (Posted: June 25, 2002)

Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication
Journal of Virology. (Posted: June 21, 2002)

Critical role for Env as well as Gag-Pol in control of a SHIV 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine
Journal of Virology. (Posted: June 21, 2002)

Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials
Vaccine. (Posted: June 21, 2002)

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
Proc. Natl. Acad. Sci. USA. (Posted: June 12, 2002)

Special issue of the journal Vaccine: several titles
Vaccine. (Posted: June 1, 2002)

Human immunodeficiency virus type 1 subtype C molecular phylogeny: Consensus sequence for an AIDS vaccine design?
Journal of Virology. (Posted: May 29, 2002)

Reduced HIV risk-taking and low HIV incidence after enrollment and risk-reduction counseling in a sexually transmitted disease prevention trial in Nairobi, Kenya
Journal of Acquired Immune Deficiency Syndromes. (Posted: May 25, 2002)

Predictors of HIV-specific lymphocyte proliferative immune responses induced by therapeutic vaccination
Clinical and Experimental Immunology. (Posted: May 24, 2002)

Fusion-competent vaccines: Broad neutralization of primary isolates of HIV (Retraction of vol 283, pg 357, 1999)
Science. (Posted: May 20, 2002)

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
Proc. Natl. Acad. Sci. USA. (Posted: May 14, 2002)

Issues for improving multiplasmid DNA vaccines for HIV-1
Vaccine. (Posted: May 14, 2002)

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric env protein boost in the SHIV rhesus macaque model
Virology. (Posted: May 7, 2002)

Prospects for an AIDS vaccine (letter)
Science. (Posted: May 7, 2002)

Prospects for vaccine protection against HIV-1 infection and AIDS
Annual Review of Immunology. (Posted: May 7, 2002)

HIV preferentially infects HIV-specific CD4+ T cells
Nature. (Posted: May 2, 2002)

A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines
Journal of Controlled Release. (Posted: April 25, 2002)

Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies
Journal of Biological Chemistry. (Posted: April 18, 2002)

HIV vaccine development in the nonhuman primate model of AIDS
Journal of Biomedical Science. (Posted: April 18, 2002)

HIV-1 polymorphism: A challenge for vaccine development - A review
Memorias do Instituto Oswaldo Cruz. (Posted: April 11, 2002)

Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques
Journal of General Virology. (Posted: April 11, 2002)

Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma
Journal of Virology. (Posted: April 11, 2002)

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022A
Journal of Acquired Immune Deficiency Syndromes. (Posted: April 3, 2002)

DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus
Journal of Medical Primatology. (Posted: April 3, 2002)

Clinical trials of HIV vaccines
Annual Review of Medicine. (Posted: April 3, 2002)

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine
Journal of Virology. (Posted: April 3, 2002)

Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate
Journal of Immunology. (Posted: March 28, 2002)

AIDS vaccine models: Challenging challenge viruses
Nature Medicine. (Posted: March 24, 2002)

Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys
Journal of Immunology. (Posted: March 4, 2002)

The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: A dynamic model
Journal of Acquired Immune Deficiency Syndromes. (Posted: March 4, 2002)

The HIV/AIDS vaccine researchers' orientation to the process of preparing a US FDA application for an investigational new drug (IND)
Vaccine. (Posted: March 4, 2002)

Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein
Vaccine. (Posted: March 4, 2002)

Vaccine development against HIV-1 - Current perspectives and future directions
Immunologic Research. (Posted: March 4, 2002)

Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy
Journal of Virology. (Posted: March 4, 2002)

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure
The Journal of Infectious Diseases. (Posted: February 19, 2002)

Some recent results on HIV pathogenesis with implications for therapy and vaccines
Cellular and Molecular Biology. (Posted: February 19, 2002)

Safety and efficacy of an oral HIV vaccine (V-1 Immunitor) in AIDS patients at various stages of the disease
HIV Clinical Trials. (Posted: February 12, 2002)

The search for an HIV vaccine
British Medical Journal. (Posted: February 5, 2002)

First trial of the HIV-1 vaccine in Africa: Ugandan experience
British Medical Journal. (Posted: February 5, 2002)

Expression of vaccinia E3L and K3L genes by a novel recombinant canarypox HIV vaccine vector enhances HIV-1 pseudovirion production and inhibits apoptosis in human cells
Virology. (Posted: February 4, 2002)

Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine
Clinical Immunology. (Posted: February 4, 2002)

A retroviral DNA vaccine vector
Viral Immunology. (Posted: January 28, 2002)

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques
Journal of General Virology. (Posted: January 28, 2002)

HIV-vaccine research takes one steps forward ... and one step back
Lancet. (Posted: January 28, 2002)

An HIV vaccine: how and when?
Bulletin of the World Health Organization. (Posted: January 28, 2002)

Potent CD4(+) T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF
Journal of Immunology. (Posted: January 28, 2002)

The past, present and future of HIV-vaccine development: a critical view
Drug Discovery Today. (Posted: January 28, 2002)

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Nature. (Posted: January 28, 2002)

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Nature. (Posted: January 28, 2002)

Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1
Immunopharmacology and Immunotoxicology. (Posted: January 28, 2002)

Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects
Eur. J. Clin. Microbiol. Infect. Dis. (Posted: January 28, 2002)

The basis for HIV immunotherapeutic vaccines
Vaccine. (Posted: January 15, 2002)

Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules
Vaccine. (Posted: January 15, 2002)

Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model
Vaccine. (Posted: January 15, 2002)

Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation
Immunobiology. (Posted: January 15, 2002)

Epidemiological considerations in planning HIV preventive vaccine trials
AIDS. (Posted: January 15, 2002)

Vaccines and immunology - Recent advances in HIV/AIDS vaccine development
AIDS. (Posted: January 15, 2002)

New insights into protective humoral responses and HIV vaccines
AIDS. (Posted: January 15, 2002)

Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?
AIDS. (Posted: January 15, 2002)

The HIV vaccine pipeline, from preclinical to phase III
AIDS. (Posted: January 15, 2002)

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine
Vaccine. (Posted: January 15, 2002)

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization
Journal of Virology. (Posted: January 14, 2002)

Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development
Immunological Reviews. (Posted: January 14, 2002)

Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys
Journal of Immunology. (Posted: January 14, 2002)

Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine
Journal of Immunology. (Posted: January 14, 2002)

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques
Nature Medicine. (Posted: January 1, 2002)

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice
Journal of Virology. (Posted: January 1, 2002)

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene
Journal of Virology. (Posted: January 1, 2002)

Imperfect vaccines and the evolution of pathogen virulence
Nature. (Posted: December 16, 2001)

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies
Journal of Virology. (Posted: December 7, 2001)

Vaccine-elicited immune responses prevent clinical AIDS in SHIV89.6P-infected rhesus monkeys
Immunol. Lett.. (Posted: November 29, 2001)

Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
Immunol. Lett.. (Posted: November 29, 2001)

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector
Vaccine. (Posted: November 28, 2001)

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes
Nature Medicine. (Posted: November 28, 2001)

HIV mucosal vaccine: Nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1-and Th2-deficient conditions
J. Immunol.. (Posted: November 28, 2001)

Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan
Vaccine. (Posted: November 28, 2001)

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins
Vaccine. (Posted: November 28, 2001)

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes
Nature Medicine. (Posted: November 8, 2001)

Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion
Journal of Virology. (Posted: November 1, 2001)

Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus
Journal of Virology. (Posted: November 1, 2001)

Recent developments in adjuvants for vaccines against infectious diseases
Biomolecular Engineering. (Posted: November 1, 2001)

HIV vaccine efforts inch forward
Journal of the American Medical Association. (Posted: October 22, 2001)

Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE
Am J Public Health. (Posted: September 18, 2001)

Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people
American Journal of Preventive Medicine. (Posted: August 30, 2001)

Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors
Journal of Virology. (Posted: August 10, 2001)

Immunomodulators and delivery systems for vaccination by mucosal routes
Trends in Biotechnology. (Posted: August 10, 2001)

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites
J. Immunol.. (Posted: August 1, 2001)

Evolution and transmission of stable CTL escape mutations in HIV infection
Nature. (Posted: July 27, 2001)

Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
MMWR. (Posted: July 16, 2001)

A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
HUMAN GENE THERAPY. (Posted: July 3, 2001)

Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine? The HIVNET Vaccine Preparedness Study
American Journal of Epidemiology. (Posted: April 2, 2001)

AIDS vaccines show promise after years of frustration
Science. (Posted: March 19, 2001)

Microbicides in HIV Prevention
British Medical Journal Online. (Posted: March 5, 2001)

Willingness to Volunteer in Future Preventive HIV Vaccine Trials: Issues and Perspectives From Three U.S. Communities
Journal of Acquired Immune Deficiency Syndromes. (Posted: February 5, 2001)

Willingness to Participate in HIV Vaccine Trials Among Men Who Have Sex with Men in Rio de Janeiro, Brazil
J. AIDS. (Posted: January 10, 2001)

                                                                                                                                                                                                                                                                                                                             


 

 

 
Privacy Policy     Site Map    
 
Published by the American Association for the Advancement of Science.
 

 
Copyright © 2003 by the American Association for the Advancement of Science.